You are here

  • Home
  • Archive
  • Volume 18, Issue 6
  • Use of diuretics with ACE inhibitors or angiotensin receptor blockers and NSAIDs increases the risk of acute kidney injury

Article Text

Article menu
Download PDFPDF
Aetiology/Harm
Cohort study
Use of diuretics with ACE inhibitors or angiotensin receptor blockers and NSAIDs increases the risk of acute kidney injury
  1. Raymond R Townsend,
  2. Debbie L Cohen
  1. Department of Medicine, Renal Division, University of Pennsylvania, Philadelphia, Pennsylvania, USA
  1. Correspondence to Dr Raymond R Townsend
    Department of Medicine, Renal Division, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA; townsend{at}mail.med.upenn.edu

http://dx.doi.org/10.1136/eb-2013-101273

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Lapi F, Azoulay L, Yin H, et al. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ 2013;346:e8525.OpenUrlAbstract/FREE Full Text

    Context

    Acute kidney injury (AKI) is increasing both in the USA and Europe.1 ,2 Most people with AKI return to baseline renal function, but AKI predisposes some patients to an increased risk of chronic kidney disease (CKD) and end-stage renal disease (ESRD).3 ,4 Medications contribute to AKI whether administered in hospital such as aminoglycoside antibiotics, or when prescribed for outpatients, such as non-steroidal anti-inflammatory drugs (NSAIDs) whose adverse effects are seen more often to involve the gastrointestinal tract rather than kidneys. Lapi and colleagues report …

    View Full Text

    Footnotes

    • Competing interests None.